BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 31131537)

  • 1. Circular RNA Cdr1as sensitizes bladder cancer to cisplatin by upregulating APAF1 expression through miR-1270 inhibition.
    Yuan W; Zhou R; Wang J; Han J; Yang X; Yu H; Lu H; Zhang X; Li P; Tao J; Wei J; Lu Q; Yang H; Gu M
    Mol Oncol; 2019 Jul; 13(7):1559-1576. PubMed ID: 31131537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CircRNA-Cdr1as Exerts Anti-Oncogenic Functions in Bladder Cancer by Sponging MicroRNA-135a.
    Li P; Yang X; Yuan W; Yang C; Zhang X; Han J; Wang J; Deng X; Yang H; Li P; Tao J; Lu Q; Gu M
    Cell Physiol Biochem; 2018; 46(4):1606-1616. PubMed ID: 29694981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing CDR1as enhances the sensitivity of breast cancer cells to drug resistance by acting as a miR-7 sponge to down-regulate REGγ.
    Yang W; Yang X; Wang X; Gu J; Zhou D; Wang Y; Yin B; Guo J; Zhou M
    J Cell Mol Med; 2019 Aug; 23(8):4921-4932. PubMed ID: 31245927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNA ACVR2A suppresses bladder cancer cells proliferation and metastasis through miR-626/EYA4 axis.
    Dong W; Bi J; Liu H; Yan D; He Q; Zhou Q; Wang Q; Xie R; Su Y; Yang M; Lin T; Huang J
    Mol Cancer; 2019 May; 18(1):95. PubMed ID: 31101108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircZNF609 promotes bladder cancer progression and inhibits cisplatin sensitivity via miR-1200/CDC25B pathway.
    Feng D; Lv J; Li K; Cao Q; Han J; Yu H; Cheng Y; Zhuang J; Cai L; Yang H; Yang X; Lu Q
    Cell Biol Toxicol; 2023 Oct; 39(5):1-18. PubMed ID: 35567596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular RNA circSLC8A1 acts as a sponge of miR-130b/miR-494 in suppressing bladder cancer progression via regulating PTEN.
    Lu Q; Liu T; Feng H; Yang R; Zhao X; Chen W; Jiang B; Qin H; Guo X; Liu M; Li L; Guo H
    Mol Cancer; 2019 Jun; 18(1):111. PubMed ID: 31228937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer.
    Nordentoft I; Birkenkamp-Demtroder K; Agerbæk M; Theodorescu D; Ostenfeld MS; Hartmann A; Borre M; Ørntoft TF; Dyrskjøt L
    BMC Med Genomics; 2012 Sep; 5():40. PubMed ID: 22954303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EIF4A3-mediated biogenesis of circSTX6 promotes bladder cancer metastasis and cisplatin resistance.
    Wei W; Liu K; Huang X; Tian S; Wang H; Zhang C; Ye J; Dong Y; An Z; Ma X; Wang B; Huang Y; Zhang X
    J Exp Clin Cancer Res; 2024 Jan; 43(1):2. PubMed ID: 38163881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA BCRC-3 suppresses bladder cancer proliferation through miR-182-5p/p27 axis.
    Xie F; Li Y; Wang M; Huang C; Tao D; Zheng F; Zhang H; Zeng F; Xiao X; Jiang G
    Mol Cancer; 2018 Oct; 17(1):144. PubMed ID: 30285878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circ_0008532 promotes bladder cancer progression by regulation of the miR-155-5p/miR-330-5p/MTGR1 axis.
    Chen L; Yang X; Zhao J; Xiong M; Almaraihah R; Chen Z; Hou T
    J Exp Clin Cancer Res; 2020 May; 39(1):94. PubMed ID: 32460831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of circular RNA CDR1as increases chemosensitivity of 5-FU-resistant BC cells through up-regulating miR-7.
    Yang W; Gu J; Wang X; Wang Y; Feng M; Zhou D; Guo J; Zhou M
    J Cell Mol Med; 2019 May; 23(5):3166-3177. PubMed ID: 30884120
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Wei W; Sun J; Zhang H; Xiao X; Huang C; Wang L; Zhong H; Jiang Y; Zhang X; Jiang G
    Cancer Res; 2021 Dec; 81(24):6142-6156. PubMed ID: 34702726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF-1α-dependent miR-424 induction confers cisplatin resistance on bladder cancer cells through down-regulation of pro-apoptotic UNC5B and SIRT4.
    Yu M; Ozaki T; Sun D; Xing H; Wei B; An J; Yang J; Gao Y; Liu S; Kong C; Zhu Y
    J Exp Clin Cancer Res; 2020 Jun; 39(1):108. PubMed ID: 32522234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. circRIP2 accelerates bladder cancer progression via miR-1305/Tgf-β2/smad3 pathway.
    Su Y; Feng W; Shi J; Chen L; Huang J; Lin T
    Mol Cancer; 2020 Feb; 19(1):23. PubMed ID: 32019579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ_0058063 regulates CDK6 to promote bladder cancer progression by sponging miR-145-5p.
    Sun M; Zhao W; Chen Z; Li M; Li S; Wu B; Bu R
    J Cell Physiol; 2019 Apr; 234(4):4812-4824. PubMed ID: 30362519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Circular RNA Cdr1as Promotes Myocardial Infarction by Mediating the Regulation of miR-7a on Its Target Genes Expression.
    Geng HH; Li R; Su YM; Xiao J; Pan M; Cai XX; Ji XP
    PLoS One; 2016; 11(3):e0151753. PubMed ID: 26998750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells.
    Lei Y; Li B; Tong S; Qi L; Hu X; Cui Y; Li Z; He W; Zu X; Wang Z; Chen M
    PLoS One; 2015; 10(2):e0117809. PubMed ID: 25658842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-34a Attenuates Metastasis and Chemoresistance of Bladder Cancer Cells by Targeting the TCF1/LEF1 Axis.
    Liu X; Liu X; Wu Y; Fang Z; Wu Q; Wu C; Hao Y; Yang X; Zhao J; Li J; Wang Q; Yang Z; Xu J; Hu X; Tan M; Li L
    Cell Physiol Biochem; 2018; 48(1):87-98. PubMed ID: 30001529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA CDR1as disrupts the p53/MDM2 complex to inhibit Gliomagenesis.
    Lou J; Hao Y; Lin K; Lyu Y; Chen M; Wang H; Zou D; Jiang X; Wang R; Jin D; Lam EW; Shao S; Liu Q; Yan J; Wang X; Chen P; Zhang B; Jin B
    Mol Cancer; 2020 Sep; 19(1):138. PubMed ID: 32894144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1.
    Hong X; Liu N; Liang Y; He Q; Yang X; Lei Y; Zhang P; Zhao Y; He S; Wang Y; Li J; Li Q; Ma J; Li Y
    Mol Cancer; 2020 Feb; 19(1):33. PubMed ID: 32061262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.